Form D — Paragon Biosciences Emalex Capital, Inc.
0001749990-25-000003 · filed 2025-07-08
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $270,000,000
- Total sold
- $270,000,000
- Minimum investment
- $1,072
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Paragon Biosciences Emalex Capital, Inc.
- CIK
- 1749990
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 303 N WABASH AVE
CHICACO, IL 60611 - Phone
- (847) 715-0606
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Patrick J. Morris · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Jeffrey Aronin · DirectorChicago, IL Find on LinkedIn ↗
-
Antonio Gracias · DirectorChicago, IL Find on LinkedIn ↗
-
Darien Parhad · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Eric Messner · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Jeffrey Dayno · DirectorChicago, IL Find on LinkedIn ↗
-
Ricky Sun · DirectorChicago, IL Find on LinkedIn ↗
View original on SEC EDGAR.